{"id":9350,"date":"2017-02-28T18:25:40","date_gmt":"2017-02-28T09:25:40","guid":{"rendered":"http:\/\/cell.brc.riken.jp\/en\/?page_id=9350"},"modified":"2017-02-28T18:26:06","modified_gmt":"2017-02-28T09:26:06","slug":"mn20170228","status":"publish","type":"page","link":"http:\/\/cell.brc.riken.jp\/en\/mail_news\/mn20170228","title":{"rendered":"RIKEN BRC Cell Bank MAILNEWS 2017.02.28"},"content":{"rendered":"<pre>\r\n*******************************************\r\nRIKEN BioResource Center Cell Bank\r\n   MAILNEWS 2017.02.28\r\n<a href=\"\/en\/\">http:\/\/cell.brc.riken.jp\/en\/<\/a>\r\n*******************************************\r\n\r\nRIKEN BioResource Center Cell Bank is announcing our new e-mail\r\nnewsletter. \r\n\r\n====Contents========================\r\n\uff65 Newly cataloged cell lines (2017.02)\r\n\uff65 Disease-specific iPS cells\r\n===================================\r\nWe hope you find the contents of this message of interest.\r\nHowever, if you would prefer to unsubscribe from future e-mails,\r\nplease send an e-mail to <a href=\"mailto:&#99;&#101;l&#108;b&#x61;nk.b&#x72;c&#x40;r&#105;ken&#46;&#x6a;&#112;\">cellbank.brc<img loading=\"lazy\" decoding=\"async\" title=\"\" alt=\"\" src=\"\/ja\/wp-content\/uploads\/images\/at.png\" width=\"13\" height=\"13\" \/>riken.jp<\/a>.\r\n\r\n===================================\r\n\uff65 Newly cataloged cell lines (2017.02)\r\n===================================\r\n<a href=\"\/en\/new_resource\">http:\/\/cell.brc.riken.jp\/en\/new_resource<\/a>\r\n\r\n## Human iPS cells (HPS)  27 cell lines ##\r\n\r\nHPS0071  Disease specific iPS cell line derived from a patient : \r\n           Mitochondrial myopathy, Encephalopathy, Lactic acidosis, \r\n           and Stroke-like episodes. HPS0070 was derived from the same \r\n           patient.\r\nHPS0240  Disease specific iPS cell line derived from a patient : \r\n           Metachromatic leukodystrophy (MLD). \r\nHPS0288  Disease specific iPS cell line derived from a patient : \r\n           Werner syndrome. \r\nHPS0313  Disease specific iPS cell line derived from a patient : \r\n           Muscular dystrophy, Duchenne type. HPS0312 was derived from\r\n           the same patient. \r\nHPS0323  Disease specific iPS cell line derived from a patient : \r\n           Muscular dystrophy, Duchenne type (manifesting carrier).  \r\n           Fibroblasts derived from the skeletal muscle tissue. HPS0317\r\n           and HPS0322 were derived from the same patient.\r\nHPS0353  Disease specific iPS cell line derived from a patient : \r\n           Inclusion body myositis. HPS0351 and HPS0352 were derived from\r\n           the same patient. \r\nHPS0383  Disease specific iPS cell line derived from a patient : \r\n           Muscular dystrophy, Duchenne type.  \r\nHPS0388  Disease specific iPS cell line derived from a patient : \r\n           Achondroplasia.  \r\nHPS0390  Disease specific iPS cell line derived from a patient : \r\n           Miyoshi myopathy. \r\nHPS0393  Disease specific iPS cell line derived from a patient : \r\n           Muscular dystrophy, Myotonic Dystrophy.  \r\nHPS0395  Disease specific iPS cell line derived from a patient :\r\n           Muscular dystrophy, Myotonic Dystrophy. \r\nHPS0397  Disease specific iPS cell line derived from a patient : \r\n           Miyoshi myopathy.  \r\nHPS0407  Disease specific iPS cell line derived from a patient :\r\n           Familial central diabetes insipidus. \r\nHPS0408  Disease specific iPS cell line derived from a patient : \r\n           Miyoshi myopathy.  \r\nHPS0523  Disease specific iPS cell line derived from a patient : \r\n           Achondroplasia. HPS0522 was derived from the same patient.\r\nHPS0525  Disease specific iPS cell line derived from a patient : \r\n           Osteogenesis Imperfecta. \r\nHPS0540  Disease specific iPS cell line derived from a patient :   \r\n           Muscular dystrophy, Myotonic Dystrophy. \r\nHPS0939  Disease specific iPS cell line derived from a patient : \r\n           Achondroplasia. \r\nHPS0945  Disease specific iPS cell line derived from a patient : \r\n           Osteogenesis Imperfecta. \r\nHPS0953  Disease specific iPS cell line derived from a patient : \r\n           Achondroplasia. \r\nHPS1010  Disease specific iPS cell line derived from a patient :\r\n           Familial central diabetes insipidus. \r\nHPS1011  Disease specific iPS cell line derived from a patient :  \r\n           Familial central diabetes insipidus.  \r\nHPS1012  Disease specific iPS cell line derived from a patient : \r\n           Best disease.\r\nHPS1013  Disease specific iPS cell line derived from a patient : \r\n           Gelatinous drop-like corneal dystrophy. \r\nHPS1072  Disease specific iPS cell line derived from a patient :\r\n           Age related Macular degeneration. \r\nHPS1745  Disease specific iPS cell line derived from a patient : \r\n           Alzheimer disease. \r\nHPS1747  Disease specific iPS cell line derived from a patient : \r\n           Alzheimer disease. \r\n\r\n## Animal ES cell lines including nuclear transferred ES cell lines and\r\ngermline stem cell lines (AES)  2 cell lines ##\r\n\r\nAES0161  Dnmt1-\/- ES (clone 36)  \r\n           Mouse ES cell line lacking Dnmt gene.\r\nAES0174  rdES2-1  \r\n           Rabbit embryonic stem (ES) cell line.\r\n\r\n##Animal iPS cells (APS)  2 cell lines ##\r\n\r\nAPS0009  iPS-L2  \r\n           Rabbit induced pluripotent stem (iPS) cell line. \r\nAPS0011  iPS-S2  \r\n           Rabbit induced pluripotent stem (iPS) cell line.\r\n\r\n##General cell lines (RCB)  19 cell lines ##\r\n\r\nRCB3600  SDR-P-1D5  \r\n           Rat cell line derived from anterior pituitary lacking growth \r\n           hormone\r\nRCB3601  SDRL-1  \r\n           Rat cell line derived from liver lacking growth hormone\r\nRCB3602  SDRL-2  \r\n           Rat cell line derived from liver lacking growth hormone\r\nRCB4477  ACK2  \r\n           Hybridoma cell line producing anti-mouse c-kit (CD117) \r\n           antibody.\r\nRCB4478  ACK4  \r\n          Hybridoma cell line producing anti-mouse c-kit (CD117) \r\n          antibody.\r\nRCB4479  ACK30  \r\n           Hybridoma cell line producing anti-mouse c-kit (CD117) \r\n           antibody\r\nRCB4480  ACK45  \r\n           Hybridoma cell line producing anti-mouse c-kit (CD117) \r\n           antibody.\r\nRCB4481  A7R34  \r\n           Hybridoma cell line producing anti-mouse IL-7 Receptor \r\n           alpha (CD127) antibody.\r\nRCB4482  APA5  \r\n           Hybridoma cell line producing anti-mouse PDGF Receptor \r\n           alpha (CD140a) antibody.\r\nRCB4483  APB5  \r\n           Hybridoma cell line producing anti-mouse PDGF Receptor \r\n           beta (CD140b) antibody.\r\nRCB4484  Avas12  \r\n           Hybridoma cell line producing anti-mouse Flk-1\/ VEGF- \r\n           Receptor 2 (CD309) antibody.\r\nRCB4485  A2F10  \r\n           Hybridoma cell line producing anti-mouse Flk-2\/Flt-3 \r\n           (CD135) antibody.\r\nRCB4486  AFS98  \r\n           Hybridoma cell line producing anti-mouse c-fms (CD115) \r\n           antibody.\r\nRCB4487  ACD1  \r\n           Hybridoma cell line producing anti-mouse CDK4 antibody.\r\nRCB4488  AFL4  \r\n           Hybridoma cell line producing anti-mouse VEGF-Receptor \r\n           3 antibody.\r\nRCB4489  MB86  \r\n           Hybridoma cell line producing anti-mouse IgM(b)\/Igh6b \r\n           antibody.\r\nRCB4548  PT-r  \r\n           Rat cell line derived from parathyroid gland.\r\nRCB4635  #16-15  \r\n           Hybridoma cell line producing anti-human BEND3 antibody \r\n           (rat IgM).\r\nRCB4662  HCT116 CMV-OsTIR1  \r\n           This is an HCT116 cell line in which CMV-OsTIR1(pMK232,\r\n           PURO) was introduced at the both alleles of the AAVS1 \r\n           locus by using CRISPR\/Cas. This parental cell line \r\n           constitutively express OsTIR1 and can be used for \r\n           generation of AID mutants.\r\n\r\n===================================\r\n\uff65 Disease-specific iPS cells\r\n===================================\r\n\r\nWe have many disease-specific iPS cell lines other than above.\r\n    68 kinds of disease in total\r\n    480 cell lines in total\r\nPlease access to the following page.\r\nURL <a href=\"\/en\/hps\/patient_specific_ips\">http:\/\/cell.brc.riken.jp\/en\/hps\/patient_specific_ips<\/a>\r\n\r\n\r\n===================================\r\n*If you have any questions or comments, please send an e-mail to\r\n<a href=\"mailto:&#99;&#101;l&#108;b&#x61;nk.b&#x72;c&#x40;r&#105;ken&#46;&#x6a;&#112;\">cellbank.brc<img loading=\"lazy\" decoding=\"async\" title=\"\" alt=\"\" src=\"\/ja\/wp-content\/uploads\/images\/at.png\" width=\"13\" height=\"13\" \/>riken.jp<\/a>.\r\n*Content is subject to change without notice.\r\n*All Rights Reserved.\r\n_________________________________________\r\nRIKEN BioResource Center Cell Bank\r\n3-1-1 Koyadai, Tsukuba-shi\r\nIbaraki, 305-0074 Japan\r\n<a href=\"mailto:&#99;&#101;l&#108;b&#x61;nk.b&#x72;c&#x40;r&#105;ken&#46;&#x6a;&#112;\">cellbank.brc<img loading=\"lazy\" decoding=\"async\" title=\"\" alt=\"\" src=\"\/ja\/wp-content\/uploads\/images\/at.png\" width=\"13\" height=\"13\" \/>riken.jp<\/a>\r\n<a href=\"\/en\/\">http:\/\/cell.brc.riken.jp\/en\/<\/a>\r\n_________________________________________\r\n2017.02.28\r\n<\/pre>\n","protected":false},"excerpt":{"rendered":"<p>******************************************* RIKEN BioResource Center Cell Bank MAILNEWS 2017.02.28 http:\/\/cell.brc.riken.jp\/en\/ ******************************************* RIKEN BioResource Center Cell Bank is announcing our new e-mail newsletter. ====Contents======================== \uff65 Newly cataloged cell lines (2017.02) \uff65 Disease-specific iPS cells =================================== We hope you find the contents of this message of interest. However, if you would prefer to unsubscribe from future e-mails, please send an e-mail to cellbank.brcriken.jp. =================================== \uff65 Newly cataloged cell lines (2017.02) =================================== http:\/\/cell.brc.riken.jp\/en\/new_resource ## Human iPS cells (HPS) 27 cell lines ## HPS0071 Disease specific iPS cell line derived from a patient : Mitochondrial myopathy, Encephalopathy, Lactic acidosis, and Stroke-like episodes. HPS0070 was derived from the same patient. HPS0240 Disease specific iPS cell line derived from a patient : Metachromatic leukodystrophy (MLD). HPS0288 Disease specific iPS cell line derived from a patient : Werner syndrome. HPS0313 Disease specific iPS cell line derived from a patient : Muscular dystrophy, Duchenne type. HPS0312 was derived from the same patient. HPS0323 Disease specific iPS cell line derived from a patient : Muscular dystrophy, Duchenne type (manifesting carrier). Fibroblasts derived from the skeletal muscle tissue. HPS0317 and HPS0322 were derived from the same patient. HPS0353 Disease specific iPS cell line derived from a patient : Inclusion body myositis. [&hellip;]<\/p>\n","protected":false},"author":15,"featured_media":0,"parent":8973,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_seopress_titles_title":"","_seopress_titles_desc":"","_seopress_robots_index":"","_seopress_robots_follow":"","_seopress_robots_imageindex":"","_seopress_robots_snippet":"","_seopress_robots_primary_cat":"","_seopress_robots_breadcrumbs":"","_seopress_robots_freeze_modified_date":"","_seopress_robots_custom_modified_date":"","_seopress_robots_canonical":"","_seopress_social_fb_title":"","_seopress_social_fb_desc":"","_seopress_social_fb_img":"","_seopress_social_fb_img_attachment_id":0,"_seopress_social_fb_img_width":0,"_seopress_social_fb_img_height":0,"_seopress_social_twitter_title":"","_seopress_social_twitter_desc":"","_seopress_social_twitter_img":"","_seopress_social_twitter_img_attachment_id":0,"_seopress_social_twitter_img_width":0,"_seopress_social_twitter_img_height":0,"_seopress_redirections_value":"","_seopress_redirections_enabled":"","_seopress_redirections_enabled_regex":"","_seopress_redirections_logged_status":"","_seopress_redirections_param":"","_seopress_redirections_type":0,"_seopress_analysis_target_kw":"","footnotes":"","_wp_rev_ctl_limit":""},"class_list":["post-9350","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"http:\/\/cell.brc.riken.jp\/en\/wp-json\/wp\/v2\/pages\/9350","targetHints":{"allow":["GET"]}}],"collection":[{"href":"http:\/\/cell.brc.riken.jp\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"http:\/\/cell.brc.riken.jp\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"http:\/\/cell.brc.riken.jp\/en\/wp-json\/wp\/v2\/users\/15"}],"replies":[{"embeddable":true,"href":"http:\/\/cell.brc.riken.jp\/en\/wp-json\/wp\/v2\/comments?post=9350"}],"version-history":[{"count":2,"href":"http:\/\/cell.brc.riken.jp\/en\/wp-json\/wp\/v2\/pages\/9350\/revisions"}],"predecessor-version":[{"id":9352,"href":"http:\/\/cell.brc.riken.jp\/en\/wp-json\/wp\/v2\/pages\/9350\/revisions\/9352"}],"up":[{"embeddable":true,"href":"http:\/\/cell.brc.riken.jp\/en\/wp-json\/wp\/v2\/pages\/8973"}],"wp:attachment":[{"href":"http:\/\/cell.brc.riken.jp\/en\/wp-json\/wp\/v2\/media?parent=9350"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}